Business, technology, markets and policy analysis from the United States
CEO & company research profile · Reviewed 2026-09-13

David Ricks: Eli Lilly

David Ricks ranks #7 in the inaugural 2026 American CEO Performance Ranking with a Meridian score of 84.1. The profile below explains why Eli Lilly is significant to the ranking and the operating evidence behind the score.

National rank

#7

Position in the 2026 American CEO Performance Ranking.

Meridian score

84.1 / 100

Composite score using the common seven-factor Meridian framework.

Company

Eli Lilly

A large, nationally significant listed company included in the inaugural research universe.

Performance signal

Exceptional medicines growth and manufacturing expansion score strongly, moderated by concentration and execution risk around capacity.

The ranking gives the greatest weight to shareholder outcomes, revenue and earnings execution, and capital efficiency. Strategic execution, innovation, workforce signals and governance provide the remaining score. This means a high position reflects a broad operating record rather than one exceptional quarter or a popularity judgement.

Scale and relevance

Eli Lilly is included because its size, market position and strategic importance make its leadership outcomes material to the national business landscape. Meridian's ranking universe prioritises companies where executive decisions can be evaluated against public financial and strategic evidence.

Evidence standard

The profile relies first on company filings, annual results and investor disclosures. Market and sector context is used to avoid rewarding structurally faster-growing industries without adjustment.

Primary evidence

View the primary or investor source used for this profile.

This page is part of a versioned research product. Scores may change as new annual results, leadership changes, major acquisitions, capital-allocation decisions or material governance events alter the evidence base.

Return to the full American CEO Performance Ranking.

David Ricks, Eli Lilly: CEO Performance Profile 2026 | American Commerce Review